Next Article in Journal
Availability and Access to Orphan Drugs for Rare Cancers in Bulgaria: Analysis of Delays and Public Expenditures
Next Article in Special Issue
Breast Cancer Polygenic Risk Score Validation and Effects of Variable Imputation
Previous Article in Journal
A Matter of Margins in Oral Cancer—How Close Is Enough?
Previous Article in Special Issue
EMP2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast Cancer
 
 
Review

Article Versions Notes

Cancers 2024, 16(8), 1483; https://doi.org/10.3390/cancers16081483
Action Date Notes Link
article xml file uploaded 12 April 2024 17:22 CEST Original file -
article xml uploaded. 12 April 2024 17:22 CEST Update https://www.mdpi.com/2072-6694/16/8/1483/xml
article pdf uploaded. 12 April 2024 17:22 CEST Version of Record https://www.mdpi.com/2072-6694/16/8/1483/pdf
article html file updated 12 April 2024 17:23 CEST Original file https://www.mdpi.com/2072-6694/16/8/1483/html
Back to TopTop